Fig. 2From: The safety and tolerability profile of bilastine for chronic urticaria in children(reproduced with permission from 28)Assessment of somnolence/sedation from baseline (D0) to week 12 (W12) according to global scores on the four domains of the Pediatric Sleep Questionnaire: sleeping-related breathing disorder (SRBD), daytime sleepiness, snoring and inattentionBack to article page